How does botulinum toxin A compare with placebo in people with cervical dystonia? | ||
| dc.conicet.organizacion | No especifíca | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Centro de Investigaciones en Epidemiología y Salud Pública. Instituto de Efectividad Clínica y Sanitaria. Centro de Investigaciones en Epidemiología y Salud Pública | |
| dc.contributor.author | Tort, Sera | |
| dc.contributor.author | Ciapponi, Agustín | |
| dc.date.issued | 2018-10 | |
| dc.description.abstract | Moderate‐quality evidence shows that botulinum toxin A in adults with moderate to severe impairment due to cervical dystonia leads to a large improvement in cervical dystonia and a moderate improvement in pain. Duration of effect and quality of life were inconsistently reported across trials, but there seemed to be an improvement in quality of life.Overall adverse events were more common with botulinum toxin A (on average, 545 vs 459 per 1000 people); when assessing specific events, more people experienced dysphagia (82 vs 27 per 1000 people) and diffuse weakness/tiredness with botulinum toxin A than with placebo (32 vs 18 per 1000 people). | es |
| dc.description.fil | Fil: Tort, Sera. No especifíca; | |
| dc.description.fil | Fil: Ciapponi, Agustín. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Centro de Investigaciones en Epidemiología y Salud Pública. Instituto de Efectividad Clínica y Sanitaria. Centro de Investigaciones en Epidemiología y Salud Pública; Argentina | |
| dc.format | application/pdf | es |
| dc.identifier.citation | Tort, Sera; Ciapponi, Agustín; How does botulinum toxin A compare with placebo in people with cervical dystonia?; Wiley; Cochrane Clinical Answers; 10-2018; 1-12 | es |
| dc.identifier.institucional | CONICET | |
| dc.identifier.issn | 2050-4217 | es |
| dc.identifier.repo | CONICET Digital | |
| dc.identifier.uri | http://hdl.handle.net/11336/185405 | |
| dc.journal.pagination | 1-12 | es |
| dc.journal.pais | Reino Unido | es |
| dc.journal.title | Cochrane Clinical Answers | es |
| dc.language.iso | eng | es |
| dc.publisher | Wiley | es |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/url/http://doi.wiley.com/10.1002/cca.2053 | |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1002/cca.2053 | |
| dc.rights | info:eu-repo/semantics/openAccess | * |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ | * |
| dc.subject | SALUD | es |
| dc.subject.classification | Otras Ciencias de la Salud | es |
| dc.subject.classification | Ciencias de la Salud | es |
| dc.subject.classification | CIENCIAS MÉDICAS Y DE LA SALUD | es |
| dc.title | How does botulinum toxin A compare with placebo in people with cervical dystonia? | es |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:ar-repo/semantics/artículo | |
| dc.type | info:eu-repo/semantics/publishedVersion | |
Archivos
Bloque original
Cargando...
- Nombre:
- CONICET_Digital_Nro.5ea3f107-7e59-4605-8330-f2a4bbdb33bc_B.pdf
- Tamaño:
- 478.66 KB
- Formato:
- Adobe Portable Document Format